drugset / Trial / NCT00460551
Zalutumumab in Combination With Chemo-Radiation in a Certain Type of Lung Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of the study is to investigate if treatment with zalutumumab in combination with chemotherapy and radiotherapy (chemo-radiation) will lead to a prolonged life in patients with lung cancer compared to patients treated with chemo-radiation alone.
Timeline
- Start
- 2007-04
- Primary completion
- 2008-10
- Completion
- 2008-10
Outcome
Outcome not reported
Stopped: “Due to considerations regarding the appropriate therapeutic regimen for these patients.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zalutumumab | Monoclonal antibody | 8 mg/kg | — |
| Background | Cisplatin | Other / unclassified | — | — |
| Background | Docetaxel | Small molecule | — | — |